StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research report sent to investors on Wednesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
Onconova Therapeutics Price Performance
The company has a market capitalization of $20.90 million, a P/E ratio of -1.09 and a beta of 1.38. Onconova Therapeutics has a 1 year low of $0.55 and a 1 year high of $1.45. The business has a 50 day simple moving average of $0.83 and a 200 day simple moving average of $0.74.
Onconova Therapeutics Company Profile
Read More
- Five stocks we like better than Onconova Therapeutics
- ESG Stocks, What Investors Should Know
- High-Yield Texas Instruments Could Hit New Highs Soon
- About the Markup Calculator
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Stock Dividend Cuts Happen Are You Ready?
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Onconova Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Onconova Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.